Latest results FY2026 · Prices updated Oct 30, 2026
HQ: Shibuya-ku, TokyoFounded 19215,633 employeesWebsite
Japan's largest medical device manufacturer. Holds top global market shares in catheters and heart-lung machines, providing high-quality medical solutions worldwide.
Business segments (share of revenue)
Latest results
FY2026
vs. same period a year earlier
Company forecastFY2027
| Segment | Share | Revenue | Operating profit | Margin |
|---|---|---|---|---|
| Cardiac and Vascular Company | 60% | ¥676.4B | ¥164.0B | 24.2% |
| Blood and Cell Technologies Company | 20% | ¥231.0B | ¥33.6B | 14.6% |
| Medical Care Solutions Company | 19% | ¥216.1B | ¥21.6B | 10.0% |
| Organ Technologies Business | 1% | ¥8.0B | ¥1.7B | 20.9% |
Close (Oct 30, 2026)
¥2,404.5-3.1% (1Y)
Terumo -3.1% over 1Y, 11.0pt below the industry average (9 companies, +7.9%).
Reference chart of daily closing prices, not real-time quotes (split-adjusted; weekly closes before the last year). Updated Oct 30, 2026.
| Period | Revenue | Op. profit | Net income | Total assets | Revenue YoY |
|---|---|---|---|---|---|
| 2026FY | ¥1.1T | ¥176.3B | ¥135.9B | ¥2.3T | +9.2% |
| 2025FY | ¥1.0T | ¥157.7B | ¥117.0B | ¥1.8T | +12.4% |
| 2024FY | ¥921.9B | ¥140.1B | ¥106.4B | ¥1.8T | +12.4% |
| 2023FY | ¥820.2B | ¥117.3B | ¥89.3B | ¥1.6T | +16.6% |
| 2022FY | ¥703.3B | ¥116.0B | ¥88.8B | ¥1.5T | +14.6% |
| 2021FY | ¥613.8B | ¥98.4B | ¥77.3B | ¥1.4T | — |
Sources: annual securities reports, earnings releases and other public disclosures (Mar 2025)
Data may contain input errors. For reference only; we accept no responsibility for its accuracy.
